CG ONCOLOGY INC (CGON)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CGON
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CGON | Director | 50 | ["More than 25 years of global pharmaceutical and biotechnology experience","Interim Chief Executive Officer at Blueprint Medicines","Chief Operating Officer of Blueprint Medicines from 2022 until its acquisition by Sanofi","Chief Commercial Officer at Blueprint Medicines","Business Unit Head, North America, at Sanofi Genzyme","Vice President, MS Sales at Sanofi Genzyme","Vice President, MS Patient and Provider Services at Sanofi Genzyme","Healthcare consultant at Boston Consulting Group","Board member at Xilio Therapeutics, Inc."] | ["Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Christina Rossi serves on the Compensation Committee.